€8.20
3.30% today
Xetra, Apr 03, 04:41 pm CET
ISIN
DE0005157101
Symbol
HNL
Index

Dr. Hönle Target price 2025 - Analyst rating & recommendation

Dr. Hönle Classifications & Recommendation:

Buy
100%

Dr. Hönle Price Target

Target Price €19.50
Price €8.48
Potential
Number of Estimates 2
2 Analysts have issued a price target Dr. Hönle 2026 . The average Dr. Hönle target price is €19.50. This is higher than the current stock price. The highest price target is
€22.00 159.43%
register free of charge
, the lowest is
€17.00 100.47%
register free of charge
.
A rating was issued by 2 analysts: 2 Analysts recommend Dr. Hönle to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Dr. Hönle stock has an average upside potential 2026 of . Most analysts recommend the Dr. Hönle stock at Purchase.

Sales and Margin forecast 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Sep '24 2025
Estimates
Revenue Million € 98.73 102.80
7.16% 4.12%
EBITDA Margin 2.17% 8.07%
381.09% 272.31%
Net Margin -13.44% 0.59%
29.60% 104.39%

2 Analysts have issued a sales forecast Dr. Hönle 2025 . The average Dr. Hönle sales estimate is

€103m
Unlock
. This is
6.69% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
€105m 9.39%
Unlock
, the lowest is
€100m 4.00%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 €98.7m 7.16%
2025
€103m 4.12%
Unlock
2026
€113m 10.07%
Unlock
2027
€123m 8.26%
Unlock

2 Analysts have issued an Dr. Hönle EBITDA forecast 2025. The average Dr. Hönle EBITDA estimate is

€8.3m
Unlock
. This is
138.51% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
€9.6m 175.86%
Unlock
, the lowest is
€7.0m 101.15%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 €2.1m 360.98%
2025
€8.3m 287.85%
Unlock
2026
€13.3m 60.24%
Unlock
2027
€14.8m 11.28%
Unlock

EBITDA Margin

2024 2.17% 381.09%
2025
8.07% 272.31%
Unlock
2026
11.75% 45.60%
Unlock
2027
12.08% 2.81%
Unlock

2 Dr. Hönle Analysts have issued a net profit forecast 2025. The average Dr. Hönle net profit estimate is

€610k
Unlock
. This is
104.70% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
€1.0m 107.94%
Unlock
, the lowest is
€180k 101.39%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 €-13.3m 20.33%
2025
€610k 104.60%
Unlock
2026
€4.2m 585.25%
Unlock
2027
€5.8m 37.80%
Unlock

Net Margin

2024 -13.44% 29.60%
2025
0.59% 104.39%
Unlock
2026
3.70% 527.12%
Unlock
2027
4.70% 27.03%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Sep '24 2025
Estimates
Earnings Per Share -2.19 0.10
20.33% 104.57%
P/E 84.80
EV/Sales 0.96

2 Analysts have issued a Dr. Hönle forecast for earnings per share. The average Dr. Hönle EPS is

€0.10
Unlock
. This is
104.67% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
€0.17 107.94%
Unlock
, the lowest is
€0.03 101.40%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 €-2.19 20.33%
2025
€0.10 104.57%
Unlock
2026
€0.69 590.00%
Unlock
2027
€0.95 37.68%
Unlock

P/E ratio

Current -3.97 53.07%
2025
84.80 2,236.02%
Unlock
2026
12.29 85.51%
Unlock
2027
8.93 27.34%
Unlock

Based on analysts' sales estimates for 2025, the Dr. Hönle stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.02 36.25%
2025
0.96 6.12%
Unlock
2026
0.87 9.15%
Unlock
2027
0.80 7.63%
Unlock

P/S ratio

Current 0.53 53.26%
2025
0.50 6.28%
Unlock
2026
0.45 9.14%
Unlock
2027
0.42 7.64%
Unlock

Current Dr. Hönle Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
HAUCK AUFHAEUSER INVESTMENT BANKING
Locked
Locked
Locked Dec 09 2024
WARBURG RESEARCH GMBH
Locked
Locked
Locked Dec 09 2024
Analyst Rating Date
Locked
HAUCK AUFHAEUSER INVESTMENT BANKING:
Locked
Locked
Dec 09 2024
Locked
WARBURG RESEARCH GMBH:
Locked
Locked
Dec 09 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today